ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,800,000 | -49.3% | 435,720 | -0.5% | 0.00% | -50.0% |
| Q3 2016 | $3,547,000 | +4.0% | 437,874 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $3,410,000 | +9.4% | 437,200 | +8.3% | 0.00% | 0.0% |
| Q1 2016 | $3,116,000 | -26.9% | 403,580 | +2.1% | 0.00% | -20.0% |
| Q4 2015 | $4,265,000 | +56.7% | 395,273 | +0.4% | 0.01% | +25.0% |
| Q3 2015 | $2,721,000 | -23.1% | 393,791 | -1.4% | 0.00% | 0.0% |
| Q2 2015 | $3,537,000 | -3.2% | 399,222 | +7.8% | 0.00% | -20.0% |
| Q1 2015 | $3,653,000 | -3.8% | 370,449 | +19.4% | 0.01% | 0.0% |
| Q4 2014 | $3,799,000 | +21.4% | 310,138 | -1.1% | 0.01% | +25.0% |
| Q3 2014 | $3,130,000 | +33.2% | 313,596 | +1.1% | 0.00% | +33.3% |
| Q2 2014 | $2,349,000 | +165.1% | 310,275 | +15.2% | 0.00% | +200.0% |
| Q1 2014 | $886,000 | -0.8% | 269,334 | +0.1% | 0.00% | 0.0% |
| Q4 2013 | $893,000 | +8.0% | 269,185 | -1.7% | 0.00% | 0.0% |
| Q3 2013 | $827,000 | -60.2% | 273,915 | +7.8% | 0.00% | -75.0% |
| Q2 2013 | $2,078,000 | – | 254,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |